UNSPSC 51182033: Metenolone

This classification denotes an anabolic agent with the molecular formula C20H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9062ZT8Q5C, chemically known as androst-1-en-3-one, 17-hydroxy-1-methyl-, (5alpha,17beta)- but generally known as metenolone, which bears US NIH Compound Identifier 9054. European Medicines Agency schedules Metenolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08823MIG.

World Health Organization schedules metenolone in its Anatomical Therapeutic Chemical (ATC) Classification. METENOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metenolone under HS 29372900 and SITC 54153. SMILES: OC1C2(C(C3C(C4(C(CC3)CC(=O)C=C4C)C)CC2)CC1)C.

UNSPSC 51182033 Metenolone is a Commodity code for a synthetic anabolic steroid used in pharmaceutical and veterinary applications. State and local governments procure metenolone primarily through health departments, correctional facilities, and animal control or veterinary service divisions for medical treatment and management purposes. The code reflects pharmaceutical procurement for controlled substances, which involves compliance with DEA scheduling, state pharmacy board regulations, and secure chain-of-custody protocols typical of regulated drug sourcing.

The most-recent-state-local-contract-opportunities block provided no records of recent solicitations under this code. Without documented recent opportunities, no geographic concentration, issuing-body patterns, or representative procurements can be identified from current market activity.